Lindbrook Capital’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-73
| Closed | -$412 | – | 2917 |
|
|
2024
Q2 | $412 | Buy |
+73
| New | +$412 | ﹤0.01% | 2665 |
|
|
2023
Q3 | – | Sell |
-673
| Closed | -$4.44K | – | 2853 |
|
|
2023
Q2 | $4.44K | Buy |
673
+561
| +501% | +$3.7K | ﹤0.01% | 1865 |
|
|
2023
Q1 | $760 | Sell |
112
-438
| -80% | -$2.97K | ﹤0.01% | 2511 |
|
|
2022
Q4 | $4.07K | Sell |
550
-96
| -15% | -$710 | ﹤0.01% | 1924 |
|
|
2022
Q3 | $6K | Sell |
646
-718
| -53% | -$6.67K | ﹤0.01% | 1609 |
|
|
2022
Q2 | $15K | Buy |
1,364
+687
| +101% | +$7.56K | ﹤0.01% | 1109 |
|
|
2022
Q1 | $8K | Buy |
677
+31
| +5% | +$366 | ﹤0.01% | 1407 |
|
|
2021
Q4 | $10K | Hold |
646
| – | – | ﹤0.01% | 1287 |
|
|
2021
Q3 | $11K | Hold |
646
| – | – | ﹤0.01% | 975 |
|
|
2021
Q2 | $14K | Hold |
646
| – | – | ﹤0.01% | 918 |
|
|
2021
Q1 | $10K | Hold |
646
| – | – | ﹤0.01% | 1033 |
|
|
2020
Q4 | $8K | Hold |
646
| – | – | ﹤0.01% | 1015 |
|
|
2020
Q3 | $6K | Buy |
646
+96
| +17% | +$892 | ﹤0.01% | 1064 |
|
|
2020
Q2 | $6K | Hold |
550
| – | – | ﹤0.01% | 1041 |
|
|
2020
Q1 | $6K | Buy |
+550
| New | +$6K | ﹤0.01% | 949 |
|